Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)
Go back to Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 33.25 +0.27 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.98 | 52 Week High | $18.62 | |||
| Open | $32.95 | 52 Week Low | $2.85 | |||
| Day High | $33.50 | P/E | N/A | |||
| Day Low | $32.63 | EPS | $-1.02 | |||
| Volume | 53,077 | |||||
